INTRACAVITARY BACILLUS CALMETTE-GUERIN IN THE TREATMENT OF SUPERFICIAL BLADDER TUMORS

被引：42
|
作者：
Morales, A. [1 ]
Eidinger, D.
Bruce, A. W.
机构：
[1] NIH, Lab Immunodiagnosis, Bldg 8,Room 118, Bethesda, MD 20014 USA
来源：
JOURNAL OF UROLOGY | 2017年 / 197卷 / 02期
关键词：
BCG; CANCER; CARCINOMA; MELANOMA; THERAPY;
D O I：
10.1016/j.juro.2016.10.101
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with recurrent superficial bladder tumors have been treated by vesical and intradermal administration of Bacillus Calmette-Guerin. The pattern of recurrence in 9 patients has been altered favorably. Although the findings are still preliminary they appear to hold promise of a new therapeutic approach to the treatment of a group of neoplasms for which effective therapy is still lacking.
引用
收藏
页码：S142 / S144
页数：3
相关论文
共 50 条
  • [21] Intravesical bacillus Calmette-Guerin versus epirubicin in the prophylaxis of recurrent and/or multiple superficial bladder tumours
    Melekos, MD
    Zarakovitis, IE
    Fokaefs, ED
    Dandinis, K
    Chionis, H
    Bouropoulos, C
    Dauaher, H
    ONCOLOGY, 1996, 53 (04) : 281 - 288
  • [22] Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer
    Librenjak, D
    Situm, M
    Eterovic, D
    Dogas, Z
    Gotovac, J
    CROATIAN MEDICAL JOURNAL, 2003, 44 (02) : 187 - 192
  • [23] Acute Arthritis Secondary to Intravesical Bacillus Calmette-Guerin for Bladder Cancer
    Raheem, O. A.
    Kalunian, K.
    Parsons, J. Kellogg
    ACTAS UROLOGICAS ESPANOLAS, 2012, 36 (08): : 461 - 466
  • [24] Bacillus Calmette-Guerin Immunotherapy for Cancer
    Cardillo, Fabiola
    Bonfim, Maiara
    da Silva Vasconcelos Sousa, Periela
    Mengel, Jose
    Ribeiro Castello-Branco, Luiz Roberto
    Pinho, Rosa Teixeira
    VACCINES, 2021, 9 (05)
  • [25] Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer
    Shepherd, Andrew R. H.
    Shepherd, Emily
    Brook, Nicholas R.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):
  • [26] Cytokines as effectors and predictors of responses in the treatment of bladder cancer by bacillus Calmette-Guerin
    Liu, Xiaoxuan
    Dowell, Alexander C.
    Patel, Prashant
    Viney, Richard P.
    Foster, Michael C.
    Porfiri, Emilio
    James, Nicholas D.
    Bryan, Richard T.
    FUTURE ONCOLOGY, 2014, 10 (08) : 1443 - 1456
  • [27] Nano-Bacillus Calmette-Guerin immunotherapies for improved bladder cancer treatment
    Zeng, Sheng
    Xing, Shaoqiang
    Zhang, Yifei
    Wang, Haifeng
    Liu, Qian
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2024, 25 (07): : 557 - 567
  • [28] Worsening of Bullous Pemphigoid Following Bacillus Calmette-Guerin Treatment for Bladder Cancer
    Johnson, Jamie L.
    West, Daniel A.
    Travers, Jeffrey B.
    JAMA DERMATOLOGY, 2013, 149 (02) : 248 - 249
  • [29] A mathematical model of combined bacillus Calmette-Guerin (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer
    Bunimovich-Mendrazitsky, Svetlana
    Gluckman, Jean Claude
    Chaskalovic, Joel
    JOURNAL OF THEORETICAL BIOLOGY, 2011, 277 (01) : 27 - 40
  • [30] Bacillus Calmette-Guerin (osis)
    Thupili, Chakradhar R.
    Chamarthi, Suresh K.
    Ghosh, Subha
    JOURNAL OF UROLOGY, 2014, 191 (06) : 1876 - 1877
12345